« Return to News | R&D Trends

Siemens Inks Deal With Wyeth For Imaging Agent

Friday, March 9, 2007 12:10 PM

Siemens Medical Solutions’ molecular imaging division has inked an agreement with Wyeth Pharmaceuticals to use a new Alzheimer’s disease imaging agent in its clinical trials.

The agent, which just recently received approval from the U.S. Food and Drug Administration (FDA), works differently then traditional molecular imaging agents such as PET scans that are less specific. The new agent is the first to specifically identify the accumulation of amyloid plaques and neuronal tangles that cause cell death in the brain.

“Molecular imaging is already revolutionizing the detection and diagnosis of diseases like Alzheimer’s; and now, it is becoming an indispensable component in the development of exciting new drug therapies, improving patient health,” said Michael Reitermann, president, Molecular Imaging, Siemens Medical Solutions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.